# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-027457
Filing Date
2023-08-10
Accepted
2023-08-10 08:25:43
Documents
74
Period of Report
2023-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-q.htm iXBRL | 10-Q | 1131187
2 |  | ex31-1.htm | EX-31.1 | 11027
3 |  | ex31-2.htm | EX-31.2 | 11447
4 |  | ex32-1.htm | EX-32.1 | 5004
| Complete submission text file | 0001493152-23-027457.txt |  | 5357810

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL SCHEMA FILE | imnn-20230630.xsd | EX-101.SCH | 47706
6 | XBRL CALCULATION FILE | imnn-20230630_cal.xml | EX-101.CAL | 62210
7 | XBRL DEFINITION FILE | imnn-20230630_def.xml | EX-101.DEF | 178900
8 | XBRL LABEL FILE | imnn-20230630_lab.xml | EX-101.LAB | 374481
9 | XBRL PRESENTATION FILE | imnn-20230630_pre.xml | EX-101.PRE | 288574
68 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 634770

Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Filer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15911 | Film No.: 231157321
SIC: 2834 Pharmaceutical Preparations